Published online before print October 30, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Surgery, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
1. Correspondence: Division of Surgical Research, Rhode Island Hospital, NAB 214, 593 Eddy St., Providence, RI 02903, USA. E-mail: jdaley{at}lifespan.org
ABSTRACT
The phenotype of wound macrophages has not been studied by direct examination of these cells, yet macrophages recruited to sites of injury are described as alternatively activated macrophages, requiring IL-4 or IL-13 for phenotypic expression. This study characterized wound macrophage phenotype in the PVA sponge wound model in mice. Eighty-five percent of wound macrophages isolated 1 day after injury expressed Gr-1, but only 20% of those isolated at 7 days expressed this antigen. Macrophages from 1-, 3-, and 7-day wounds expressed markers of alternative activation, including mannose receptor, dectin-1, arginase 1, and Ym1, but did not contain iNOS. Day 1 wound macrophages produced more TNF-
, more IL-6, and less TGF-β than Day 7 wound macrophages. Wound macrophages did not produce IL-10. The cytokines considered necessary for alternative activation of macrophages, IL-4 and IL-13, were not detected in the wound environment and were not produced by wound cells. Wound macrophages did not contain PStat6. Wound fluids inhibited IL-13-dependent phosphorylation of Stat6 and contained IL-13R
2, a soluble decoy receptor for IL-13. The phenotype of wound macrophages was not altered in mice lacking IL-4R
, which is required for Stat6-dependent signaling of IL-4 and IL-13. Wound macrophages exhibit a complex phenotype, which includes traits associated with alternative and classical activation and changes as the wound matures. The wound macrophage phenotype does not require IL-4 or IL-13.
Key Words: IL-4 IL-13 IL-4 receptor
mannose receptor arginase Ym1
Related Article
J. Leukoc. Biol. 2010 87: 19-21.